Improvement of the Pharmacokinetics and In Vivo Antibacterial Efficacy of a Novel Type IIa Topoisomerase Inhibitor by Formulation in Liposomes

類似資料

• NBTI 5463 Is a Novel Bacterial Type II Topoisomerase Inhibitor with Activity against Gram-Negative Bacteria and In Vivo Efficacy
  著者:: Dougherty, Thomas J., 等
  出版事項: (2014)
• ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures
  著者:: Casas, A, 等
  出版事項: (2002)
• Newly Identified Antibacterial Compounds Are Topoisomerase Poisons in African Trypanosomes
  著者:: Tang, Sonya C., 等
  出版事項: (2010)
• Pharmacokinetics and Efficacies of Liposomal and Conventional Formulations of Tobramycin after Intratracheal Administration in Rats with Pulmonary Burkholderia cepacia Infection
  著者:: Marier, Jean-Francois, 等
  出版事項: (2002)
• Treatment of Visceral Leishmaniasis with Sterically Stabilized Liposomes Containing Camptothecin
  著者:: Proulx, Marie-Eve, 等
  出版事項: (2001)